ALX Oncology Holdings(ALXO)
$1.04-0.04 (-3.70%)
ALXO
ALX Oncology Holdings financials statements
$1.04
At close:-0.04 (-3.70%)
Want to see ALXO full AI Analyst Report?
ALX Oncology Holdings (ALXO) Financial Statements
462 Followers
ALX Oncology Holdings Financial Overview
ALX Oncology Holdings's market cap is currently $149.34M. The company's EPS TTM is $-1.13; its P/E ratio is -0.92; ALX Oncology Holdings has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -872.00K | $ -836.00K | $ 0.00 | $ -736.00K |
| Operating Income | $ -104.02M | $ -142.47M | $ -170.28M | $ -127.44M | $ -83.56M |
| EBITDA | $ -99.39M | $ -132.25M | $ -158.40M | $ -122.84M | $ -83.42M |
| Net Income | $ -101.69M | $ -134.85M | $ -160.81M | $ -123.48M | $ -83.46M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 44.79M | $ 127.76M | $ 182.74M | $ 266.21M | $ 363.67M |
| Total Assets | $ 59.05M | $ 147.78M | $ 242.55M | $ 306.49M | $ 380.18M |
| Total Debt | $ 5.22M | $ 16.98M | $ 17.20M | $ 10.43M | $ 742.00K |
| Net Debt | $ -11.16M | $ -589.00K | $ -5.21M | $ -38.39M | $ -362.93M |
| Total Liabilities | $ 33.06M | $ 34.16M | $ 52.84M | $ 43.02M | $ 17.13M |
| Stockholders' Equity | $ 25.98M | $ 113.62M | $ 189.71M | $ 263.46M | $ 363.05M |
| Cash Flow | |||||
| Free Cash Flow | $ -84.35M | $ -122.36M | $ -131.64M | $ -90.65M | $ -73.02M |
| Operating Cash Flow | $ -84.14M | $ -121.91M | $ -130.36M | $ -89.22M | $ -68.10M |
| Investing Cash Flow | $ 82.59M | $ 86.26M | $ 44.66M | $ -235.42M | $ -4.92M |
| Financing Cash Flow | $ 362.00K | $ 30.82M | $ 59.29M | $ 9.86M | $ 2.47M |
Currency in USD
